Aveanna Healthcare (AVAH) Insider Vii Sells $7.4M of Stock

Inside the Large Institutional Sale at Aveanna Healthcare Holdings Inc.

On June 24, 2026, LLC J.H. Whitney Equity Partners Vii parted with 919,389 shares of Aveanna Healthcare Holdings Inc. AVAH. The transaction was executed at a price of $8.00 per share, bringing the total value of the sale to roughly $7.36 million. This move formed part of a coordinated wave of significant divestments by major backers on the exact same day.

Broad Insider Activity Alongside J.H. Whitney

The sale by LLC J.H. Whitney Equity Partners Vii did not happen in isolation. On June 24, 2026, other key stakeholders also trimmed their holdings substantially. Robert Williams disposed of 1,000,000 shares at $8.00 apiece for a total of $8.00 million. At the identical price, Paul Vigano let go of 1,000,000 shares valued at $8.00 million. These concurrent transactions by major holders represented a notable reduction of shares in a single session.

Aveanna Healthcare Stock Performance and Market Context

Aveanna Healthcare Holdings Inc. AVAH shares trade on the NasdaqGS, reflecting recent market interest as analysts evaluate the company's trajectory. The home care provider operates against a backdrop of varied market sentiment, with ten analysts currently offering opinions on the stock.

Analysts Set New Price Targets

Wall Street firms have actively adjusted their outlooks on the stock over recent weeks. On July 14, 2026, Truist Securities maintained a hold rating with a $11.00 price target. Later, on August 14, 2026, BMO Capital kept an outperform rating with a $14.00 target, while Raymond James maintained a strong buy and set a $15.00 target. UBS maintained a neutral rating on August 14, 2026, moving its target to $13.00. RBC Capital kept an outperform rating on August 24, 2026, with a target of $16.00, and Truist Securities maintained a hold with a $15.00 target on the same day. Barclays kept an overweight rating on August 28, 2026, setting a target of $15.00. Most recently, on September 14, 2026, JP Morgan maintained a neutral rating with a $15.00 price target. Overall, the stock carries a consensus buy recommendation.

What Aveanna Healthcare Does

Based in Atlanta, Georgia, Aveanna Healthcare Holdings Inc. operates as a diversified home care platform company providing pediatric and adult healthcare services across the United States. Its patient-centered care delivery model helps patients remain in their homes while reducing reliance on high-cost institutional settings like hospitals. The company delivers private duty nursing, home health, hospice care, and enteral nutrition supplies through its specialized operating segments.

What to Watch Next for AVAH

Investors tracking the healthcare provider will monitor upcoming corporate disclosures and filing updates for further clarity on institutional positioning. Because 13F filings and insider reports look backward, these records show historical snapshots rather than real-time intentions. No investment decision should be made based solely on past insider sales.